Immunology & Microbial Sciences

Activities

Activities per year 1974 2001 2023

• 743 Participation in conference
• 343 Publication peer-review
• 221 Types of External academic engagement - Membership of external research organisation
• 140 Editorial activity
• 511 More
  • 107 Types of External academic engagement - Contribution to the work of national or international committees and working groups
  • 73 Types of External academic engagement - Membership of peer review panel or committee
  • 69 Types of External academic engagement - Invited talk
  • 66 Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
  • 55 Invited talk
  • 32 Participation in workshop, seminar, course
  • 24 Types of External academic engagement - Research and Teaching at External Organisation
  • 12 Types of Public engagement and outreach - Media article or participation
  • 12 Oral presentation
  • 9 Types of Business and Community - Other
  • 9 Types of Public engagement and outreach - Public lecture/debate/seminar
  • 8 Examination
  • 8 Types of Public engagement and outreach - Schools engagement
  • 7 Types of Award - Other distinction
  • 5 Types of Award - Fellowship awarded competitively
  • 3 Types of Business and Community - Membership of public/government advisory/policy group or panel
  • 3 Types of External academic engagement - Hosting an academic visitor
  • 2 Types of Business and Community - CPD delivery/organisation of courses for externals (in kind)
  • 2 Types of Public engagement and outreach - Work on advisory panels for social community and cultural engagement
  • 1 Consultancy
  • 1 Membership of council
  • 1 Types of Award - Appointment
  • 1 Types of Award - Prize (including medals and awards)
  • 1 Types of Public engagement and outreach - Festival/Exhibition

Activities per year

Search results

• Targeting spliced epitopes in anti-cancer immunotherapy

  Mishto, M. (Invited speaker)

  7 Sept 2021

  Activity: Talk or presentation › Invited talk

• How to illuminate the dark side of HLA class I immunopeptidomes

  Mishto, M. (Invited speaker)

  14 Aug 2021

  Activity: Talk or presentation › Invited talk

• 2004-2021: what we know about post-translational peptide splicing

  Mishto, M. (Keynote speaker)

  29 Jul 2021

  Activity: Talk or presentation › Invited talk

• What unconventional epitopes do cancer T cells see?

  Mishto, M. (Invited speaker)

  28 Jan 2021

  Activity: Talk or presentation › Invited talk

• Splicing or non-splicing: do T cells care?

  Mishto, M. (Invited speaker)

  8 Jan 2021

  Activity: Talk or presentation › Invited talk

• Severe Asthma - When and Who to Refer

  Jackson, D. (Speaker)

  25 Jul 2020

  Activity: Talk or presentation › Invited talk

• 2004-2020: what we know about post-translational peptide splicing

  Mishto, M. (Keynote speaker)

  14 Jul 2020

  Activity: Talk or presentation › Invited talk

• Real world Experience of Benralizumab in Severe Asthma

  Jackson, D. (Speaker)

  25 Jun 2020

  Activity: Talk or presentation › Invited talk

• Asthma Biologics: RWE in the Spotlight

  Jackson, D. (Speaker)

  Jun 2020

  Activity: Talk or presentation › Invited talk

• Biologics in Severe Asthma

  Jackson, D. (Speaker)

  27 Apr 2020

  Activity: Talk or presentation › Invited talk

• BEYOND CLINICAL TRIALS: managing Severe Eosinophilic Asthma in Practice

  Jackson, D. (Speaker)

  7 Apr 2020

  Activity: Talk or presentation › Invited talk

• Mitigating antibody-mediated rejection in the highly sensitised candidate: Identification and treatment

  Dorling, A. (Speaker)

  5 Mar 2020

  Activity: Talk or presentation › Invited talk

• Optimising care in Severe Asthma

  Jackson, D. (Speaker)

  Mar 2020

  Activity: Talk or presentation › Invited talk

• Epitope target discovery: what can we see when we think outside the box?”

  Mishto, M. (Invited speaker)

  15 Jan 2020

  Activity: Talk or presentation › Invited talk

• Convalescent Plasma Therapy as a Treatment for COVID-19

  Shankar-Hari, M. (Speaker)

  2020

  Activity: Talk or presentation › Invited talk

• INVESTIGATION OF PREDICTIVE SIGNATURES OF DISEASE ACTIVITY AND DEVELOPMENT OF NOVEL THERAPEUTIC TARGETS IN SYSTEMIC LUPUS ERYTHEMATOSUS

  Scotta, C. (Speaker)

  5 Dec 2019

  Activity: Talk or presentation › Invited talk

• Challenging Oral Steroid use in Asthma

  Jackson, D. (Speaker)

  2 Nov 2019

  Activity: Talk or presentation › Invited talk

• Immunological and therapeutic relevance of post-translationally spliced peptides

  Mishto, M. (Invited speaker)

  24 Oct 2019

  Activity: Talk or presentation › Invited talk

• Throwing a spanner in the works: post-translationally spliced peptides and the immune system

  Mishto, M. (Invited speaker)

  21 Oct 2019

  Activity: Talk or presentation › Invited talk

• The role of the gut microbiome in alcohol-related steatohepatitis (ASH) and non-alcohol related steatohepatitis (NASH)

  Patel, V. C. (Speaker)

  8 Oct 2019

  Activity: Talk or presentation › Invited talk

• BOPPP and CALIBRE Trials Symposium – Investigator Update

  Patel, V. C. (Speaker)

  18 Sept 2019

  Activity: Talk or presentation › Invited talk

• Intestinal barrier and systemic inflammation in cirrhosis (Gut-Brain Axis session)

  Patel, V. C. (Speaker)

  14 Sept 2019

  Activity: Talk or presentation › Invited talk

• Identification of conventional and unconventional targets for immunotherapie

  Mishto, M. (Invited speaker)

  2 Aug 2019

  Activity: Talk or presentation › Invited talk

• Environment, epigenome and asthma

  Lavender, P. (Speaker)

  4 Jun 2019

  Activity: Talk or presentation › Invited talk

• What we learned about peptide splicing in the last two years

  Mishto, M. (Invited speaker)

  30 May 2019

  Activity: Talk or presentation › Invited talk

• Beta blockers Or Placebo for Primary Prophylaxis of oesophageal varices in cirrhosis (BOPPP Trial): a triple blinded, multi-centre, clinical- and cost-effectiveness randomised controlled trial – Investigator Update

  Patel, V. C. (Speaker)

  1 May 2019

  Activity: Talk or presentation › Invited talk

• The role of the gut-liver axis in autoimmune liver diseases

  Patel, V. C. (Speaker)

  25 Apr 2019

  Activity: Talk or presentation › Invited talk

• Is it worth to search among post-translationally spliced peptides to develop anti-cancer immunotherapies?

  Mishto, M. (Invited speaker)

  12 Apr 2019

  Activity: Talk or presentation › Invited talk

• Proteasome-catalysed peptide splicing

  Mishto, M. (Invited speaker)

  5 Feb 2019

  Activity: Talk or presentation › Invited talk

• Proteasome research in 2019 and beyond

  Mishto, M. (Invited speaker)

  20 Nov 2018

  Activity: Talk or presentation › Invited talk

• Targeting unconventional epitopes in anti-cancer immunotherapy

  Mishto, M. (Invited speaker) & Hayday, A. C. (Invited speaker)

  26 Jun 2018

  Activity: Talk or presentation › Invited talk

• The role of the micro- and mycobiome in chronic liver disease

  Patel, V. C. (Speaker)

  11 Jun 2018

  Activity: Talk or presentation › Invited talk

• Epigenetic control of of gene expression and epigenome editing in asthma

  Lavender, P. (Speaker)

  29 May 2018

  Activity: Talk or presentation › Invited talk

• Post-translational peptide splicing and T cell responses

  Mishto, M. (Invited speaker)

  4 May 2018

  Activity: Talk or presentation › Invited talk

• New Targets on the block: Proteasome-generated spliced epitopes

  Mishto, M. (Invited speaker)

  26 Mar 2018

  Activity: Talk or presentation › Invited talk

• Proteasome-catalysed peptide splicing at the edge between self and non-self

  Mishto, M. (Invited speaker)

  12 Jan 2018

  Activity: Talk or presentation › Invited talk

• Acute-on-Chronic Liver Failure: Pathophysiology & the gut microbiome

  Patel, V. C. (Speaker)

  2018

  Activity: Talk or presentation › Invited talk

• Septic encephalopathy in cirrhosis and the critical care environment

  Patel, V. C. (Speaker)

  2018

  Activity: Talk or presentation › Invited talk

• Proteasome-catalysed peptide splicing: at the edge between self and non-self

  Mishto, M. (Invited speaker)

  1 Dec 2017

  Activity: Talk or presentation › Invited talk

• Out of the Box and Out of the Cell: How Extracellular Proteasome can regulate Inflammation and Cell Infiltration

  Mishto, M. (Invited speaker)

  14 Jul 2017

  Activity: Talk or presentation › Invited talk

• Proteasome-generated spliced peptides

  Mishto, M. (Invited speaker)

  5 Jul 2017

  Activity: Talk or presentation › Invited talk

• The Dark Side of the HLA-I Immunopeptidome is populated by Proteasome-generated Spliced Peptides

  Mishto, M. (Invited speaker)

  8 Jun 2017

  Activity: Talk or presentation › Invited talk

• Acute Alcoholic Hepatitis: Current evidence & management

  Patel, V. C. (Speaker)

  2017

  Activity: Talk or presentation › Invited talk

• Hepatic Encephalopathy: Optimising Detection & Management

  Patel, V. C. (Speaker)

  2017

  Activity: Talk or presentation › Invited talk

• Pathogenesis of Hepatic Encephalopathy:- Key role of the neutrophil and ammonia (Microbiome Assessment Techniques & Hepatological Insights)

  Patel, V. C. (Speaker)

  2017

  Activity: Talk or presentation › Invited talk

• Defining the Pathogenic Relationship of the Gut Microbiota in Acute-on-Chronic Liver Failure

  Patel, V. C. (Speaker)

  2016

  Activity: Talk or presentation › Invited talk

• Acute Variceal Haemorrhage: Optimising management in the 21st century

  Patel, V. C. (Speaker)

  2016

  Activity: Talk or presentation › Invited talk

• Acute Alcoholic Hepatitis: Current evidence & management

  Patel, V. C. (Speaker)

  2016

  Activity: Talk or presentation › Invited talk

• Potential roles of immunoproteasome in epilepsy

  Mishto, M. (Speaker)

  2016

  Activity: Talk or presentation › Invited talk

• The Pathogenic Relationship of the Host Microbiota with the Gut–Liver–Brain Axis

  Patel, V. C. (Speaker)

  2016

  Activity: Talk or presentation › Invited talk